R. J. Kreitman

775 citations

26 papers · 634 indexed · h-index 14

Biotechnology top 2%
- Transgenic Plants and Applications 13
- Microbial Inactivation Methods 4
- Cancer Research and Treatments 2
Immunology top 5%
- Toxin Mechanisms and Immunotoxins 18
Radiology, Nuclear Medicine and Imaging top 10%
- Monoclonal and Polyclonal Antibodies Research 10
Genetics
- Chronic Lymphocytic Leukemia Research 4
Oncology
Ecology
- Bacteriophages and microbial interactions 4
Pulmonary and Respiratory Medicine
- Occupational and environmental lung diseases 3

Co-authors: Ira Pastan D J FitzGerald David J. FitzGerald I Pastan Clay B. Siegall Inger Margulies Raj K. Puri Waldemar Debinski
Cited by: Biotechnology Immunology Radiology, Nuclear Medicine and Imaging
Partner nations: United States United Kingdom Netherlands

In The Last Decade

R. J. Kreitman

25 papers receiving 623 citations

Peers

Countries citing papers authored by R. J. Kreitman

Since Specialization

Citations

This map shows the geographic impact of R. J. Kreitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. J. Kreitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. J. Kreitman more than expected).

Fields of papers citing papers by R. J. Kreitman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. J. Kreitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. J. Kreitman. The network helps show where R. J. Kreitman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside R. J. Kreitman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R. J. Kreitman Line = papers co-authored together R. J. Kreitman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Non-V600E BRAF mutations and treatment for hairy cell leukemia Evgeny Arons,Chin‐Hsien Tai,Joshi Suraj,Yuelin Liu,Chi‐Ping Day,Mark Raffeld,Liqiang Xi,(unknown),M N Gould,Isaac Shpilman,(unknown),Seema A. Bhat,Michael R. Grever,Daniel Jones,Kerry A. Rogers,Hao‐Wei Wang,Constance M. Yuan,(unknown),R. J. Kreitman	2024	4
2	Generation of Chimeric Toxins David Fitzgerald,V K Chaudhary,R. J. Kreitman,Clay B. Siegall,Ira Pastan	2020	0
3	Phase I trial of recombinant immunotoxin CAT-8015 (HA22) in multiply relapsed hairy cell leukemia. R. J. Kreitman,M. S. Tallman,Steven Coutré,Tadeusz Robak,Wyndham H. Wilson,M Stetler-Stevenson,Pierre Noël,David Fitzgerald,Jennifer McDevitt,Ira Pastan	2010	6
4	Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin for targeted therapy of mesothelin expressing mesotheliomas, ovarian and pancreatic cancer Raffit Hassan,S. Bullock,A Premkumar,R. J. Kreitman,Hedy L. Kindler,Mark C. Willingham,Ira Pastan	2007	4
5	Targeted therapy of mesothelin expressing mesotheliomas (MM), ovarian cancer (OC) and pancreatic cancer (PC): Results of phase I study of SS1(dsFv)PE38 (SS1P) Raffit Hassan,S. Bullock,R. J. Kreitman,Hedy L. Kindler,Ira Pastan	2004	2
6	Long term follow-up of BL22 in cladribine-resistant hairy cell leukemia R. J. Kreitman,Wyndham H. Wilson,M Stetler-Stevenson,Patricia Noël,Ira Pastan	2004	1
7	Toxin-Labeled Monoclonal Antibodies R. J. Kreitman	2001	43
8	Immunotoxins R. J. Kreitman	2000	26
9	Cytotoxic activity of disulfide-stabilized recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) toward fresh malignant cells from patients with B-cell leukemias. R. J. Kreitman,Inger Margulies,M Stetler-Stevenson,Qingcheng Wang,D J FitzGerald,I Pastan	2000	74
10	An scFv phage clone that binds to human β2-microglobulin Biru Jwang,Noga Yerushalmi,R. J. Kreitman,Jan Engberg,Ira Pastan	1999	2
11	111Indium-labeled monoclonal antibody K1: Biodistribution study in nude mice bearing a human carcinoma xenograft expressing mesothelin Raffit Hassan,Chuanchu Wu,Martin W. Brechbiel,Inger Margulies,R. J. Kreitman,Ira Pastan	1999	35
12	Toxicology and Pharmacokinetics of DT388-GM-CSF, a Fusion Toxin Consisting of a Truncated Diphtheria Toxin (DT388) Linked to Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in C57BL/6 Mice Philip D. Hall,R. J. Kreitman,Mark C. Willingham,Arthur E. Frankel	1998	11
13	Diphtheria toxin fused to GM-CSF in combination with ARA-C exerts synergistic toxicity to human AML (HL60) cells K. M. Bhalia,R. J. Kreitman,Peter Hall,A. Frankel	1998	1
14	Anti‐Tac(Fab)‐PE40, a recombinant double‐chain immunotoxin which kills interleukin‐2‐receptor‐bearing cells and induces complete remission in an in vivo tumor model R. J. Kreitman,Chung Nan Chang,D Hudson,Cary Queen,Pascal Bailon,Ira Pastan	1994	11
15	A chimeric protein comprised of IL-4 and Pseudomonas exotoxin is cytotoxic for activated human lymphocytes. Raj K. Puri,P T Mehrotra,Pamela Leland,R. J. Kreitman,Jay P. Siegel,Ira Pastan	1994	15
16	Single-chain immunotoxin fusions between anti-tac and Pseudomonas exotoxin: Relative importance of the two toxin disulfide bonds R. J. Kreitman,Janendra K. Batra,Saraswathy Seetharam,Vijay K. Chaudhary,David J. FitzGerald,I Pastan	1993	64
17	Cytotoxic effects of vascular smooth muscle cells of the chimeric toxin, heparin binding TGF -Pseudomonas exotoxin Yamin Fu,Enrique A. Mesri,Zu‐Xi Yu,R. J. Kreitman,Ira Pastan,Stephen E. Epstein	1993	10
18	Rational design of a chimeric toxin: an intramolecular location for the insertion of transforming growth factor .alpha. within Pseudomonas exotoxin as a targeting ligand R. J. Kreitman,Vijay Chaudhary,Clay B. Siegall,David Fitzgerald,Ira Pastan	1992	19
19	Properties of chimeric toxins with two recognition domains: interleukin 6 and transforming growth factor .alpha. at different locations in Pseudomonas exotoxin R. J. Kreitman,Clay B. Siegall,Vijay Chaudhary,David J. FitzGerald,Ira Pastan	1992	31
20	Antitumor effects of interleukin 6-Pseudomonas exotoxin chimeric molecules against the human hepatocellular carcinoma, PLC/PRF/5 in mice. Clay B. Siegall,R. J. Kreitman,David J. FitzGerald,Ira Pastan	1991	31

About R. J. Kreitman

R. J. Kreitman is a scholar working on Biotechnology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 26 papers that have together received 634 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (18 papers), Transgenic Plants and Applications (13 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Bacteriophages and microbial interactions (4 papers), Microbial Inactivation Methods (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Occupational and environmental lung diseases (3 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Biotechnology (265 citations), Immunology (434 citations) and Radiology, Nuclear Medicine and Imaging (192 citations). R. J. Kreitman has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Ira Pastan, D J FitzGerald, David J. FitzGerald, Ira Pastan, I Pastan, Clay B. Siegall, Inger Margulies, Raj K. Puri, Waldemar Debinski and M Stetler-Stevenson.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact